Kristine Kuchta

ORCID: 0000-0003-2484-6302
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Esophageal and GI Pathology
  • Gastroesophageal reflux and treatments
  • Breast Cancer Treatment Studies
  • Pancreatic and Hepatic Oncology Research
  • Hernia repair and management
  • Dysphagia Assessment and Management
  • Eosinophilic Esophagitis
  • Surgical Simulation and Training
  • Breast Implant and Reconstruction
  • Pelvic and Acetabular Injuries
  • Gallbladder and Bile Duct Disorders
  • BRCA gene mutations in cancer
  • Thyroid Cancer Diagnosis and Treatment
  • Bariatric Surgery and Outcomes
  • Global Cancer Incidence and Screening
  • Bladder and Urothelial Cancer Treatments
  • Appendicitis Diagnosis and Management
  • Thyroid and Parathyroid Surgery
  • Anatomy and Medical Technology
  • Lung Cancer Treatments and Mutations
  • Pituitary Gland Disorders and Treatments
  • Gastrointestinal Tumor Research and Treatment
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Reconstructive Surgery and Microvascular Techniques
  • Ovarian cancer diagnosis and treatment

NorthShore University HealthSystem
2016-2025

University of Chicago
2017-2023

Evanston Hospital
2019-2023

National Hospital
2022

The University of Texas Southwestern Medical Center
2022

Southwestern Medical Center
2022

University Hospitals of Cleveland
2022

Waterbury Hospital
2022

University of Chicago Medical Center
2022

American College of Surgeons
2018-2022

Background and Objectives The authors sought to study patient-reported outcomes following nipple-sparing mastectomy (NSM). Methods From 2008 2011, the BREAST-Q was administered women undergoing NSM surgery for cancer treatment or risk-reduction prior at 2 years after completion of reconstruction. change in score over time impact surgical indication, complication occurrence, laterality on scores were analyzed. Results prospectively 39 (n = 17) (RR) 22). At operation, median overall...

10.1002/jso.24364 article EN Journal of Surgical Oncology 2016-07-08

This cohort study builds on previous research from the National Cancer Database to assess whether rates of bilateral mastectomy continue increase.

10.1001/jamanetworkopen.2022.51348 article EN cc-by-nc-nd JAMA Network Open 2023-01-18

Abstract Background Reports on the safety of minimally invasive pancreaticoduodenectomy compared to open (OPD) have demonstrated mixed results. One study comparing robotic (RPD) vs OPD decreased complications associated with RPD. Objectives To evaluate morbidity RPD using a national data set. Methods This is retrospective cohort from 2014 2017. Factors in patients undergoing were evaluated multivariate logistic regression (MVA) and propensity score matching (PSM). Results Of 13 110 PDs...

10.1002/jso.25942 article EN Journal of Surgical Oncology 2020-05-23

Aims: To explore patient experiences in a large-scale primary care-based, preemptive genetic testing program. Methods: Patients who received results from the initiative were invited to participate an online survey 3 weeks postresult disclosure. A 6-month follow-up was sent assess changes over time. Results: The initial completed by 1646 patients, with 544 completing survey. following outcomes high overall: patient-reported understanding of (cancer: 87%; cardiac: 86%); perceived utility...

10.1089/gtmb.2020.0275 article EN cc-by-nc Genetic Testing and Molecular Biomarkers 2021-02-01

The scalable delivery of genomic medicine requires collaboration between genetics and non-genetics providers. Thus, it is essential to investigate address the perceived value barriers incorporating genetic testing into clinical practice primary care providers (PCPs). We used a mixed-methods approach qualitative interviews surveys explore experience PCPs involved in pilot DNA-10K population program. Similar previous research, reported low confidence with tasks related ordering, interpreting...

10.3390/jpm10040165 article EN Journal of Personalized Medicine 2020-10-13

The National Comprehensive Cancer Network recommends imaging within 6 months after treatment for head and neck cancer (HNC). Further is recommended only if the patient has symptoms or abnormal findings on physical examination. However, in many instances, asymptomatic patients continue to have evaluations.To assess practice patterns surveillance with HNC evaluate costs associated these practices.This single-institution retrospective economic evaluation study screened 435 identify newly...

10.1001/jamaoto.2021.0835 article EN JAMA Otolaryngology–Head & Neck Surgery 2021-05-13
Coming Soon ...